Amikacin Dosing for MDR Tuberculosis: A Systematic Review to Establish or Revise the Current Recommended Dose for Tuberculosis Treatment-Reference-Cited by-同舟云学术

Amikacin Dosing for MDR Tuberculosis: A Systematic Review to Establish or Revise the Current Recommended Dose for Tuberculosis Treatment

Author:

Sturkenboom Marieke G G¹,Simbar Noviana¹,Akkerman Onno W²³,Ghimire Samiksha¹,Bolhuis Mathieu S¹,Alffenaar Jan-Willem C¹

Affiliation:

1. University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology

2. University of Groningen, University Medical Center Groningen, Department of Pulmonology and Tuberculosis

3. University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Groningen, The Netherlands

Funder

World Health Organization

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

Reference26 articles.

2. The early bactericidal activity of amikacin in pulmonary tuberculosis;Donald;Int J Tuberc Lung Dis,2001

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Therapeutic drug monitoring in tuberculosis;European Journal of Clinical Pharmacology;2024-09-06